GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Colinz Laboratories Ltd (BOM:531210) » Definitions » Marketable Securities

Colinz Laboratories (BOM:531210) Marketable Securities : ₹40.54 Mil (As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Colinz Laboratories Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Colinz Laboratories's Marketable Securities for the quarter that ended in Mar. 2024 was ₹40.54 Mil.

Colinz Laboratories's annual Marketable Securities increased from Mar. 2022 (₹31.18 Mil) to Mar. 2023 (₹37.63 Mil) and increased from Mar. 2023 (₹37.63 Mil) to Mar. 2024 (₹40.54 Mil).


Colinz Laboratories Marketable Securities Historical Data

The historical data trend for Colinz Laboratories's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Colinz Laboratories Marketable Securities Chart

Colinz Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.84 32.87 31.18 37.63 40.54

Colinz Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23 Mar24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 37.63 - - 40.54

Colinz Laboratories Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Colinz Laboratories  (BOM:531210) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Colinz Laboratories Marketable Securities Related Terms

Thank you for viewing the detailed overview of Colinz Laboratories's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Colinz Laboratories (BOM:531210) Business Description

Traded in Other Exchanges
N/A
Address
Mulund Goregaon Link Road, A-101 Pratik Industrial Estate, Next to Fortis Hospital, Bhandup (West), Mumbai, MH, IND, 400078
Colinz Laboratories Ltd is an India based company engaged in manufacturing of pharmaceutical formulations. It offers formulations in the products category of ayurvedic, allopathy, and nutraceuticals. The company manufactures pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectables, ointments, creams, and others. It also has certain specialized products for gynecology, cardiology, gastroenterology, and others. The group derives revenue from the sale of its products in India.

Colinz Laboratories (BOM:531210) Headlines

No Headlines